Ferric maltol information

Ferric maltol
Clinical data
Trade names	Accrufer, Feraccru
AHFS/Drugs.com	Monograph
License data	EU EMA: by INN; US DailyMed: Ferric_maltol;
Routes of; administration	By mouth
Drug class	Hematologic agents
ATC code	B03AB10 (WHO) ;
Legal status
Legal status	UK: POM (Prescription only); US: ℞-only; EU: Rx-only; In general: ℞ (Prescription only);
Pharmacokinetic data
Metabolism	Glucuronidation (maltol)
Elimination half-life	0.7 hrs (maltol)
Excretion	Urine (maltol)
Identifiers
	IUPAC name Iron(3+) tris(2-methyl-4-oxo-4H-pyran-3-olate);
CAS Number	33725-54-1;
PubChem CID	169535;
DrugBank	DB876;
ChemSpider	148265;
UNII	MA10QYF1Z0;
KEGG	D10833;
CompTox Dashboard (EPA)	DTXSID10955335 ;
Chemical and physical data
Formula	C18H15FeO9
Molar mass	431.154 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].[Fe+3];
	InChI InChI=1S/3C6H6O3.Fe/c31-4-6(8)5(7)2-3-9-4;/h32-3,8H,1H3;/q;;;+3/p-3; Key:AHPWLYJHTFAWKI-UHFFFAOYSA-K;

Ferric maltol, sold under the brand names Accrufer (US) and Feraccru (EU), is an iron containing medication for the treatment of adults with low iron stores. It is taken by mouth.^[2]^[4]

^ "Feraccru 30mg hard capsules - Summary of Product Characteristics (SmPC)". electronic medicines compendium (emc). 7 February 2019. Archived from the original on 23 November 2019. Retrieved 23 November 2019.
^ ^a ^b "Drug Trials Snapshots: Accrufer". U.S. Food and Drug Administration (FDA). 15 August 2019. Archived from the original on 23 November 2019. Retrieved 23 November 2019. This article incorporates text from this source, which is in the public domain.
^ Cite error: The named reference FDA Drug Approval Package was invoked but never defined (see the help page).
^ ^a ^b "Feraccru EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 23 November 2019. Retrieved 23 November 2019. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

[1] "Feraccru 30mg hard capsules - Summary of Product Characteristics (SmPC)". electronic medicines compendium (emc). 7 February 2019. Archived from the original on 23 November 2019. Retrieved 23 November 2019.

[FDA_Snapshot-2] "Drug Trials Snapshots: Accrufer". U.S. Food and Drug Administration (FDA). 15 August 2019. Archived from the original on 23 November 2019. Retrieved 23 November 2019. This article incorporates text from this source, which is in the public domain.

[FDA_Drug_Approval_Package-3] Cite error: The named reference FDA Drug Approval Package was invoked but never defined (see the help page).

[Feraccru_EPAR-4] "Feraccru EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 23 November 2019. Retrieved 23 November 2019. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

Ferric maltol information

and 8 Related for: Ferric maltol information

Ferric maltol

Maltol

Iron supplement

Iron deficiency

ATC code B03

List of food additives

International Numbering System for Food Additives

E number